Search research articles
Contact Us
Filters
Showing results (301-310 of 418) with videos related to
Page
of 42
Sort By:
Prostate Cancer and Prostatic Diseases
|
January 25, 2026
Risk of bone fractures in patients with prostate cancer treated with maximal androgen blockade therapy: a systematic literature review and meta-analysis
Isabella Saporita, Mariangela Calabrese, Federica Maria Carfi, et al.
BMC Cancer
|
August 3, 2006
Safety of a 3-weekly schedule of carboplatin plus pegylated liposomal doxorubicin as first line chemotherapy in patients with ovarian cancer: preliminary results of the MITO-2 randomized trial
Sandro Pignata, Giovanni Scambia, Antonella Savarese, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 28, 2011
Phase I-II trial of gemcitabine-based first-line chemotherapies for small cell lung cancer in elderly patients with performance status 0-2: the G-STEP trial
Cesare Gridelli, Ciro Gallo, Alessandro Morabito, et al.
Endocrine
|
March 24, 2018
Predictivity of clinical, laboratory and imaging findings in diagnostic definition of palpable thyroid nodules. A multicenter prospective study
Maria Grazia Chiofalo, Simona Signoriello, Franco Fulciniti, et al.
Plos One
|
August 6, 2010
Time spent for activation of non-profit studies in oncology in Italy
Gianfranco De Feo, Simona Signoriello, Jane C Bryce, et al.
Clinical Lung Cancer
|
December 15, 2016
Patients' Attitudes and Physicians' Perceptions Toward Maintenance Therapy for Advanced Non-Small-cell Lung Cancer: A Multicenter Italian Survey
Maria Vittoria Pacchiana, Enrica Capelletto, Simona Carnio, et al.
The Lancet Regional Health. Europe
|
October 24, 2024
Withdrawal notice to <Corrigendum to "Comparison of baseline patient characteristics in Italian oncology drug monitoring registries and clinical trials: a real-world cross-sectional study" [The Lancet Regional Health - Europe 41 (2024) 100912]>
Maria Lucia Iacovino, Simone Celant, Luca Tomassini, et al.
The Lancet Regional Health. Europe
|
April 26, 2024
Comparison of baseline patient characteristics in Italian oncology drug monitoring registries and clinical trials: a real-world cross-sectional study
Maria Lucia Iacovino, Simone Celant, Luca Tomassini, et al.
The Lancet. Oncology
|
September 1, 2005
Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trials
Massimo Di Maio, Cesare Gridelli, Ciro Gallo, et al.
BMC Cancer
|
February 18, 2011
Effects on quality of life of weekly docetaxel-based chemotherapy in patients with locally advanced or metastatic breast cancer: results of a single-centre randomized phase 3 trial
Francesco Nuzzo, Alessandro Morabito, Adriano Gravina, et al.
Page
of 42
Search research articles
Search
Showing results (301-310 of 418) with videos related to
Sort By:
Page
of 42
Prostate Cancer and Prostatic Diseases
|
January 25, 2026
Risk of bone fractures in patients with prostate cancer treated with maximal androgen blockade therapy: a systematic literature review and meta-analysis
Isabella Saporita, Mariangela Calabrese, Federica Maria Carfi, et al.
BMC Cancer
|
August 3, 2006
Safety of a 3-weekly schedule of carboplatin plus pegylated liposomal doxorubicin as first line chemotherapy in patients with ovarian cancer: preliminary results of the MITO-2 randomized trial
Sandro Pignata, Giovanni Scambia, Antonella Savarese, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 28, 2011
Phase I-II trial of gemcitabine-based first-line chemotherapies for small cell lung cancer in elderly patients with performance status 0-2: the G-STEP trial
Cesare Gridelli, Ciro Gallo, Alessandro Morabito, et al.
Endocrine
|
March 24, 2018
Predictivity of clinical, laboratory and imaging findings in diagnostic definition of palpable thyroid nodules. A multicenter prospective study
Maria Grazia Chiofalo, Simona Signoriello, Franco Fulciniti, et al.
Plos One
|
August 6, 2010
Time spent for activation of non-profit studies in oncology in Italy
Gianfranco De Feo, Simona Signoriello, Jane C Bryce, et al.
Clinical Lung Cancer
|
December 15, 2016
Patients' Attitudes and Physicians' Perceptions Toward Maintenance Therapy for Advanced Non-Small-cell Lung Cancer: A Multicenter Italian Survey
Maria Vittoria Pacchiana, Enrica Capelletto, Simona Carnio, et al.
The Lancet Regional Health. Europe
|
October 24, 2024
Withdrawal notice to <Corrigendum to "Comparison of baseline patient characteristics in Italian oncology drug monitoring registries and clinical trials: a real-world cross-sectional study" [The Lancet Regional Health - Europe 41 (2024) 100912]>
Maria Lucia Iacovino, Simone Celant, Luca Tomassini, et al.
The Lancet Regional Health. Europe
|
April 26, 2024
Comparison of baseline patient characteristics in Italian oncology drug monitoring registries and clinical trials: a real-world cross-sectional study
Maria Lucia Iacovino, Simone Celant, Luca Tomassini, et al.
The Lancet. Oncology
|
September 1, 2005
Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trials
Massimo Di Maio, Cesare Gridelli, Ciro Gallo, et al.
BMC Cancer
|
February 18, 2011
Effects on quality of life of weekly docetaxel-based chemotherapy in patients with locally advanced or metastatic breast cancer: results of a single-centre randomized phase 3 trial
Francesco Nuzzo, Alessandro Morabito, Adriano Gravina, et al.
Page
of 42